INVO BioScience Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2015
2016
2017
2018
Net Income before Extraordinaries
4,959.20
2,124.30
702.20
3,076.10
Depreciation, Depletion & Amortization
5.60
1.90
2.80
5.20
Other Funds
4,423.50
1,263.60
256.00
2,458.80
Funds from Operations
530.10
858.80
443.40
612.10
Changes in Working Capital
378.50
534.90
262.10
40.90
Net Operating Cash Flow
151.60
323.90
181.30
653
Capital Expenditures
-
15.70
-
Net Investing Cash Flow
-
15.70
-
Issuance/Reduction of Debt, Net
20.00
-
-
Net Financing Cash Flow
625.00
-
54.60
Net Change in Cash
473.40
339.60
126.60
Free Cash Flow
151.60
339.60
181.30
Change in Capital Stock
645.00
-
54.60

About INVO BioScience

View Profile
Address
407R Mystic Avenue
Medford Massachusetts 02155
United States
Employees -
Website http://www.invobioscience.com
Updated 07/08/2019
INVO BioScience, Inc. is a medical device company, which focuses on the creation of treatment options for patients diagnosed with infertility. It offers a patented medical device that is used for infertility treatment under the name INVOcell. The company was founded by Kathleen Karloff and Claude Ranoux on January 5, 2007 and is headquartered in Medford, MA.